−0.64
Alnylam Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
−0.54
FY23:
0.10
FY24:
−0.01
FY25:
0.52
Change from FY21 to FY25
billions USD
FY21:
−0.27
FY22:
0.17
FY23:
−0.34
FY24:
−0.12
FY25:
0.44
Change from FY21 to FY25
billions USD
FY21:
1.25
FY22:
0.43
FY23:
0.17
FY24:
0.29
FY25:
−0.31
billions USD
FY21:
0.32
FY22:
0.05
FY23:
−0.05
FY24:
0.15
FY25:
0.69
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.72
FY22:
−0.61
FY23:
0.04
FY24:
−0.04
FY25:
0.47
All amounts in billions USD